Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.
AXA stock performance snapshot
AXA (ENXTPA:CS) has attracted investor attention after recent share price moves, with the stock showing mixed returns over the past week, month and past 3 months against a backdrop of steady reported revenues and profits.
See our latest analysis for AXA.
At a share price of €38.44, AXA has seen a 6.7% 3 month share price pullback. However, the 1 year total shareholder return of 2.16% and 5 year total shareholder return of 130.14% highlight a stronger longer term picture.
If AXA's mixed momentum has you thinking about diversification, it could be a good moment to scan for other ideas using the 98 top founder-led companies
With AXA trading at €38.44, and with an indicated discount to some valuation estimates, the key question now is whether the stock is meaningfully undervalued or if the market is already pricing in future growth.
Most Popular Narrative: 16.5% Undervalued
AXA's most followed valuation narrative puts fair value at €46.05, above the current €38.44 share price, framing the stock as materially underpriced on those assumptions.
Strong momentum in digitalization, AI adoption, and streamlined direct distribution (bolstered by the Prima acquisition) is expected to drive future cost efficiencies, improved customer acquisition, and expanded market share among digitally savvy, price-sensitive, and underserved customer segments, supporting higher future revenue growth and net margins.
Curious what kind of revenue growth, margin profile and earnings multiple are baked into that fair value figure? The narrative connects all three in a tight equation that could materially influence how AXA's long term earnings power and rerating potential are viewed.
The valuation work behind this narrative uses a 6.29% discount rate and links AXA's fair value to projected gains in profitability, scale and earnings quality rather than a simple market multiple comparison.
Result: Fair Value of €46.05 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on execution. Softer reinsurance pricing and ambitious cost saving and digital plans both carry clear potential to derail the upbeat valuation story.
Find out about the key risks to this AXA narrative.
Next Steps
Given the mix of optimism and caution so far, it makes sense to review the numbers and form your own view quickly. Start with the 4 key rewards and 1 important warning sign.
Looking for more investment ideas?
If you stop at AXA, you risk missing out on other opportunities that match your goals, so use the tools available and widen your watchlist smartly.
-
Target income first by scanning for companies that have paid-out strength with the 471 dividend fortresses .
-
Hunt for value by checking companies that pair quality fundamentals with attractive pricing through the 223 high quality undervalued stocks .
-
Prioritise resilience by focusing on businesses with strong financial footing using the solid balance sheet and fundamentals stocks screener (383 results) .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CS.PA .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
